Akt pathway activation by human T-cell leukemia virus type 1 tax oncoprotein

Mathew A. Cherian, Hicham H. Baydoun, Jacob Al-Saleem, Nikoloz Shkriabai, Mamuka Kvaratskhelia, Patrick Green, Lee Ratner

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Human T-cell leukemia virus (HTLV) type 1, the etiological agent of adult T-cell leukemia, expresses the viral oncoprotein Tax1. In contrast, HTLV-2, which expresses Tax2, is non-leukemogenic. One difference between these homologous proteins is the presence of a C-terminal PDZ domain-binding motif (PBM) in Tax1, previously reported to be important for non-canonical NFκB activation. In contrast, this study finds no defect in noncanonical NFκB activity by deletion of the Tax1 PBM. Instead, Tax1 PBM was found to be important for Akt activation. Tax1 attenuates the effects of negative regulators of the PI3K-Aktmammalian target of rapamycin pathway, phosphatase and tensin homologue (PTEN), and PHLPP. Tax1 competes with PTEN for binding to DLG-1, unlike a PBM deletion mutant of Tax1. Forced membrane expression of PTEN or PHLPP overcame the effects of Tax1, as measured by levels of Akt phosphorylation, and rates of Akt dephosphorylation. The current findings suggest that Akt activation may explain the differences in transforming activity of HTLV-1 and -2.

Original languageEnglish
Pages (from-to)26270-26281
Number of pages12
JournalJournal of Biological Chemistry
Volume290
Issue number43
DOIs
StatePublished - Oct 23 2015

Fingerprint

Dive into the research topics of 'Akt pathway activation by human T-cell leukemia virus type 1 tax oncoprotein'. Together they form a unique fingerprint.

Cite this